Florent Belon

Part of CryoPort, Inc., Cell&Co SAS is a premium solution provider for logistic and storage of biological samples and pharmaceutical products. The company is based in Clermont-Ferrand, France. The French company offers compliant and high-quality services for clinical studies of phase I, II, and III, with tailored solutions for precision biomedical research. In addition to storing biocollections in ultra-secure BPF infrastructures, Cell&Co provides centralized management of all logistics flows. The company was founded by Sofien Dessolin, Florent Belon, Alexandre Léglise, Michel Pautrat, Jean-François Félix. Florent Belon has been the CEO since incorporation. Cell&Co was acquired by CryoPort, Inc. on April 18, 2022 for $9.38 million.

Part of CryoPort, Inc., Cell&Co SAS is a premium solution provider for logistic and storage of biological samples and pharmaceutical products. The company is based in Clermont-Ferrand, France. The French company offers compliant and high-quality services for clinical studies of phase I, II, and III, with tailored solutions for precision biomedical research. In addition to storing biocollections in ultra-secure BPF infrastructures, Cell&Co provides centralized management of all logistics flows. The company was founded by Sofien Dessolin, Florent Belon, Alexandre Léglise, Michel Pautrat, Jean-François Félix. Florent Belon has been the CEO since incorporation. Cell&Co was acquired by CryoPort, Inc. on April 18, 2022 for $9.38 million.

Part of CryoPort, Inc., Cell&Co SAS is a premium solution provider for logistic and storage of biological samples and pharmaceutical products. The company is based in Clermont-Ferrand, France. The French company offers compliant and high-quality services for clinical studies of phase I, II, and III, with tailored solutions for precision biomedical research. In addition to storing biocollections in ultra-secure BPF infrastructures, Cell&Co provides centralized management of all logistics flows. The company was founded by Sofien Dessolin, Florent Belon, Alexandre Léglise, Michel Pautrat, Jean-François Félix. Florent Belon has been the CEO since incorporation. Cell&Co was acquired by CryoPort, Inc. on April 18, 2022 for $9.38 million.

Part of CryoPort, Inc., Cell&Co SAS is a premium solution provider for logistic and storage of biological samples and pharmaceutical products. The company is based in Clermont-Ferrand, France. The French company offers compliant and high-quality services for clinical studies of phase I, II, and III, with tailored solutions for precision biomedical research. In addition to storing biocollections in ultra-secure BPF infrastructures, Cell&Co provides centralized management of all logistics flows. The company was founded by Sofien Dessolin, Florent Belon, Alexandre Léglise, Michel Pautrat, Jean-François Félix. Florent Belon has been the CEO since incorporation. Cell&Co was acquired by CryoPort, Inc. on April 18, 2022 for $9.38 million.

Part of CryoPort, Inc., Cell&Co SAS is a premium solution provider for logistic and storage of biological samples and pharmaceutical products. The company is based in Clermont-Ferrand, France. The French company offers compliant and high-quality services for clinical studies of phase I, II, and III, with tailored solutions for precision biomedical research. In addition to storing biocollections in ultra-secure BPF infrastructures, Cell&Co provides centralized management of all logistics flows. The company was founded by Sofien Dessolin, Florent Belon, Alexandre Léglise, Michel Pautrat, Jean-François Félix. Florent Belon has been the CEO since incorporation. Cell&Co was acquired by CryoPort, Inc. on April 18, 2022 for $9.38 million.